Literature DB >> 17603028

Human glycine alpha1 receptor inhibition by quercetin is abolished or inversed by alpha267 mutations in transmembrane domain 2.

Byung-Hwan Lee1, Jun-Ho Lee, In-Soo Yoon, Joon-Hee Lee, Sun-Hye Choi, Mi Kyung Pyo, Sang Min Jeong, Woo-Sung Choi, Tae-Joon Shin, Sang-Mok Lee, Hyewhon Rhim, Yong-Sun Park, Ye Sun Han, Hyun-Dong Paik, Ssang-Goo Cho, Cheon-Ho Kim, Yoong-Ho Lim, Seung-Yeol Nah.   

Abstract

Quercetin, one of the flavonoids, is a compound of low molecular weight found in fruits and vegetables. Besides its antioxidative effect, quercetin also shows a wide range of diverse neuropharmacological actions. However, the cellular mechanisms of quercetin's actions, especially on ligand-gated ion channels and synaptic transmissions, are not well studied. We investigated the effect of quercetin on the human glycine alpha1 receptor channel expressed in Xenopus oocytes using a two-electrode voltage clamp technique. Application of quercetin reversibly inhibited glycine-induced current (I(Gly)). Quercetin's inhibition depends on its dose, with an IC(50) of 21.5+/-.2 microM. The inhibition was sensitive to membrane voltages. Site-directed mutations of S267 to S267Y but not S267A, S267F, S267G, S267K, S267L and S267T at transmembrane domain 2 (TM2) nearly abolished quercetin-induced inhibition of I(Gly). In contrast, in site-directed mutant receptors such as S267 to S267I, S267R and S267V, quercetin enhanced I(Gly) compared to the wild-type receptor. The EC(50) was 22.6+/-1.4, 25.5+/-4.2, and 14.5+/-3.1 microM for S267I, S267R and S267V, respectively. These results indicate that quercetin might regulate the human glycine alpha(1) receptor via interaction with amino acid residue alpha267 and that alpha267 plays a key role in determining the regulatory consequences of the human glycine alpha1 receptor by quercetin.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17603028     DOI: 10.1016/j.brainres.2007.05.057

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  6 in total

1.  Quercetin Inhibits α3β4 Nicotinic Acetylcholine Receptor-Mediated Ion Currents Expressed in Xenopus Oocytes.

Authors:  Byung-Hwan Lee; Sung-Hee Hwang; Sun-Hye Choi; Tae-Joon Shin; Jiyeon Kang; Sang-Mok Lee; Seung-Yeol Nah
Journal:  Korean J Physiol Pharmacol       Date:  2011-02-28       Impact factor: 2.016

2.  Inhibitory Effects of Quercetin on Muscle-type of Nicotinic Acetylcholine Receptor-Mediated Ion Currents Expressed in Xenopus Oocytes.

Authors:  Byung-Hwan Lee; Tae-Joon Shin; Sung-Hee Hwang; Sun-Hye Choi; Jiyeon Kang; Hyeon-Joong Kim; Chan-Woo Park; Soo-Han Lee; Seung-Yeol Nah
Journal:  Korean J Physiol Pharmacol       Date:  2011-08-31       Impact factor: 2.016

3.  The effects of quercetin on seizure, inflammation parameters and oxidative stress in acute on chronic tramadol intoxication.

Authors:  Samaneh Nakhaee; Khadijeh Farrokhfall; Ebrahim Miri-Moghaddam; Mohsen Foadoddini; Masoumeh Askari; Omid Mehrpour
Journal:  BMC Pharmacol Toxicol       Date:  2021-10-19       Impact factor: 2.483

4.  The effects of naloxone, diazepam, and quercetin on seizure and sedation in acute on chronic tramadol administration: an experimental study.

Authors:  Samaneh Nakhaee; Khadijeh Farrokhfall; Ebrahim Miri-Moghaddam; Mohsen Foadoddini; Masoumeh Askari; Alireza Amirabadizadeh; Jeffrey Brent; Bruno Megarbane; Omid Mehrpour
Journal:  Behav Brain Funct       Date:  2021-05-29       Impact factor: 3.759

5.  Differential Effects of Quercetin and Quercetin Glycosides on Human α7 Nicotinic Acetylcholine Receptor-Mediated Ion Currents.

Authors:  Byung-Hwan Lee; Sun-Hye Choi; Hyeon-Joong Kim; Seok-Won Jung; Sung-Hee Hwang; Mi-Kyung Pyo; Hyewhon Rhim; Hyoung-Chun Kim; Ho-Kyoung Kim; Sang-Mok Lee; Seung-Yeol Nah
Journal:  Biomol Ther (Seoul)       Date:  2016-04-25       Impact factor: 4.634

Review 6.  Potential Therapeutic Targets of Quercetin and Its Derivatives: Its Role in the Therapy of Cognitive Impairment.

Authors:  Md Jakaria; Shofiul Azam; Song-Hee Jo; In-Su Kim; Raju Dash; Dong-Kug Choi
Journal:  J Clin Med       Date:  2019-10-25       Impact factor: 4.241

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.